Related Experiment Video
Updated: Mar 29, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
NF-Y activates genes of metabolic pathways altered in cancer cells
Paolo Benatti1, Maria Luisa Chiaramonte2, Mariangela Lorenzo2
1Dipartimento di Scienze della Vita, Università di Modena e Reggio Emilia, Modena, Italy.
Abstract:
The trimeric transcription factor NF-Y binds to the CCAAT box, an element enriched in promoters of genes overexpressed in tumors. Previous studies on the NF-Y regulome identified the general term metabolism as significantly enriched. We dissect here in detail the targeting of metabolic genes by integrating analysis of NF-Y genomic binding and profilings after inactivation of NF-Y subunits in different cell types. NF-Y controls de novo biosynthetic pathways of lipids, teaming up with the master SREBPs regulators. It activates glycolytic genes, but, surprisingly, is neutral or represses mitochondrial respiratory genes. NF-Y targets the SOCG (Serine, One Carbon, Glycine) and Glutamine pathways, as well as genes involved in the biosynthesis of polyamines and purines. Specific cancer-driving nodes are generally under NF-Y control. Altogether, these data delineate a coherent strategy to promote expression of metabolic genes fuelling anaerobic energy production and other anabolic pathways commonly altered in cancer cells.
Insights
The transcription factor NF-Y (Nuclear Factor Y) regulates metabolic genes crucial for cancer cell growth. It promotes anabolic pathways and glycolysis while repressing mitochondrial respiration, fueling tumor progression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Metabolic Regulation
Background:
- The transcription factor NF-Y binds to the CCAAT box, a DNA sequence found in promoters of genes overexpressed in tumors.
- Previous studies indicated that NF-Y regulates genes involved in metabolism.
Purpose of the Study:
- To dissect the specific metabolic genes targeted by NF-Y.
- To integrate genomic binding data with gene expression profiles after NF-Y subunit inactivation.
Main Methods:
- Genomic binding analysis of NF-Y.
- Gene expression profiling after inactivation of NF-Y subunits in various cell types.
Main Results:
- NF-Y controls de novo lipid biosynthesis in conjunction with SREBPs.
- NF-Y activates glycolytic genes but represses mitochondrial respiratory genes.
- NF-Y targets key metabolic pathways including SOCG, glutamine, polyamine, and purine biosynthesis.
Conclusions:
- NF-Y orchestrates a metabolic strategy favoring anaerobic energy production and anabolic pathways common in cancer.
- NF-Y directly controls critical cancer-driving metabolic nodes.
- These findings reveal NF-Y's role in reprogramming cellular metabolism for tumor growth.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Induced Pluripotent Stem Cells
Somatic...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes